Go Pro
→ Buy this stock today (From Chaikin Analytics) (Ad)tc pixel Free AXSM Stock Alerts

Axsome Therapeutics (AXSM) Short Interest Ratio & Short Volume

Axsome Therapeutics logo
$221.64 -8.36 (-3.63%)
Closing price 07/20/2026 04:00 PM Eastern
Extended Trading
$226.08 +4.44 (+2.00%)
As of 07/20/2026 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Axsome Therapeutics Short Interest Overview

As of June 30, 2026, Axsome Therapeutics (AXSM) had a short interest of 2.63 million shares sold short, representing 6.45% of the public float. This marks a -19.75% decrease in short interest since the prior report. The short interest ratio (days to cover) is 1.6, meaning it would take 1.6 days of the average trading volume of 1.21 million shares to cover all short positions.

Current Short Interest
2,634,115 shares
Previous Short Interest
3,282,463 shares
Change Vs. Previous Month
-19.75%
Dollar Volume Sold Short
$644.75 million
Short Interest Ratio
1.6 Days to Cover
Last Record Date
June 30, 2026
Outstanding Shares
51,460,000 shares
Short Percent of Float
6.45%
Today's Trading Volume
776,378 shares
Average Trading Volume
1,207,515 shares
Today's Volume Vs. Average
64%
Short Selling Axsome Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Axsome Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

AXSM Short Interest Over Time

AXSM Days to Cover Over Time

AXSM Percentage of Float Shorted Over Time

Axsome Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20262,634,115 shares $644.75 million -19.8%6.4%1.61 $244.77
6/15/20263,282,463 shares $831.78 million +6.1%8.0%4.8 $253.40
5/29/20263,093,253 shares $725.31 million +11.4%7.6%4.99 $234.48
5/15/20262,777,088 shares $632.40 million +1.0%6.8%2.93 $227.72
4/30/20262,748,577 shares $571.02 million +2.6%6.7%3.37 $207.75
4/15/20262,677,936 shares $493.22 million -5.4%6.6%4.55 $184.18
3/31/20262,829,669 shares $478.27 million +2.4%6.9%4.89 $169.02
3/13/20262,764,086 shares $431.42 million +6.5%7.0%4.97 $156.08
2/27/20262,594,445 shares $425.20 million -4.4%6.3%4.11 $163.89
2/13/20262,714,327 shares $491.86 million +0.0%6.6%5.06 $181.21
1/30/20262,713,173 shares $499.90 million +0.1%6.9%4.06 $184.25
1/15/20262,710,389 shares $471.99 million -0.5%6.9%3.19 $174.14
12/31/20252,723,923 shares $497.50 million -3.9%7.0%3.84 $182.64
12/15/20252,835,683 shares $414.69 million -16.7%7.2%5.8 $146.24
11/28/20253,404,883 shares $497.93 million +0.3%8.7%6.01 $146.24
11/14/20253,393,844 shares $474.09 million -5.9%8.8%5.48 $139.69
10/31/20253,604,602 shares $486.59 million +4.9%9.3%7.92 $134.99
10/15/20253,440,000 shares $445.76 million +1.8%8.9%6.3 $129.58
9/30/20253,380,000 shares $410.50 million -2.0%N/A5.9 $121.45
9/15/20253,450,000 shares $402.89 million -1.7%N/A5.7 $116.78
8/31/20253,510,000 shares $425.69 million -5.7%9.1%5.6 $121.28
8/15/20253,720,000 shares $406.26 million +1.4%N/A5.9 $109.21
7/31/20253,670,000 shares $372.06 million +1.1%9.5%5.7 $101.38
7/15/20253,630,000 shares $399.74 million -11.0%N/A5.6 $110.12
6/30/20254,080,000 shares $425.91 million +1.5%10.7%5.9 $104.39
6/15/20254,020,000 shares $418.48 million +3.6%10.5%5.5 $104.10
5/31/20253,880,000 shares $407.09 million -0.3%10.3%5.5 $104.92
5/15/20253,890,000 shares $417.09 million -7.4%10.3%5.4 $107.22
4/30/20254,200,000 shares $471.62 million -5.0%N/A4.9 $112.29
4/15/20254,420,000 shares $458.93 million -14.2%11.7%5 $103.83
3/31/20255,150,000 shares $600.64 million +4.9%13.6%5.5 $116.63
3/15/20254,910,000 shares $598.58 million -14.0%13.0%5.2 $121.91
2/28/20255,710,000 shares $728.25 million -2.7%15.1%6.2 $127.54
2/15/20255,870,000 shares $769.85 million +4.6%15.5%6.5 $131.15
1/31/20255,610,000 shares $597.24 million -2.4%N/A6.6 $106.46
1/15/20255,750,000 shares $539.06 million -13.1%N/A8.3 $93.75
12/31/20246,620,000 shares $560.12 million +1.5%N/A11.2 $84.61
12/15/20246,520,000 shares $587.45 million -7.9%N/A13.4 $90.10
11/30/20247,080,000 shares $695.40 million -7.9%N/A15.4 $98.22
11/15/20247,690,000 shares $716.48 million +1.5%N/A16.1 $93.17
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
10/31/20247,580,000 shares $674.85 million +0.8%N/A18.4 $89.03
10/15/20247,520,000 shares $649.95 million -3.1%N/A17 $86.43
9/30/20247,760,000 shares $697.39 million +1.2%N/A16.1 $89.87
9/15/20247,670,000 shares $718.45 million +0.8%N/A14 $93.67
8/31/20247,610,000 shares $676.22 million -0.8%N/A11.9 $88.86
8/15/20247,670,000 shares $656.63 million -5.8%N/A11.8 $85.61
7/31/20248,140,000 shares $710.70 million -1.7%N/A12 $87.31
7/15/20248,280,000 shares $685.58 million -3.5%N/A12 $82.80
6/30/20248,580,000 shares $690.69 million -3.5%N/A12.6 $80.50
6/15/20248,890,000 shares $654.57 million +7.5%N/A13.4 $73.63
5/31/20248,270,000 shares $607.27 million +9.0%N/A12.2 $73.43
5/15/20247,590,000 shares $576.31 million -1.6%N/A11.4 $75.93
4/30/20247,710,000 shares $568.69 million -0.5%N/A10.5 $73.76
4/15/20247,750,000 shares $528.63 million +1.3%N/A10.7 $68.21
3/31/20247,650,000 shares $610.47 million +4.8%N/A10.4 $79.80
3/15/20247,300,000 shares $551.44 million -2.3%N/A9.4 $75.54
2/29/20247,470,000 shares $607.91 million -0.7%N/A10.2 $81.38
2/15/20247,520,000 shares $702.82 million +0.4%N/A10.9 $93.46
1/31/20247,490,000 shares $674.32 million -10.0%N/A11.5 $90.03
1/15/20248,320,000 shares $708.95 million -1.2%N/A11.9 $85.21
12/31/20238,420,000 shares $670.15 million +0.7%N/A12.4 $79.59
12/15/20238,360,000 shares $610.20 million -1.1%N/A12.6 $72.99
11/30/20238,450,000 shares $569.95 million +10.6%N/A12.3 $67.45
11/15/20237,640,000 shares $460.00 million +4.0%N/A11.5 $60.21
10/31/20237,350,000 shares $457.76 million -3.2%N/A11 $62.28
10/15/20237,590,000 shares $504.51 million +1.6%N/A10.9 $66.47
9/30/20237,470,000 shares $522.08 million -8.0%N/A10.4 $69.89
9/15/20238,120,000 shares $611.11 million -1.5%N/A9.6 $75.26
8/31/20238,240,000 shares $665.79 million -3.5%N/A9.3 $80.80
8/15/20238,540,000 shares $609.41 million -5.7%N/A9.4 $71.36
7/31/20239,060,000 shares $710.94 million -2.6%N/A9.6 $78.47
7/15/20239,300,000 shares $684.76 million +1.8%N/A10.5 $73.63
6/30/20239,140,000 shares $656.80 million +17.8%24.5%10.1 $71.86
6/15/20237,760,000 shares $656.73 million +0.3%22.2%9.9 $84.63
5/31/20237,740,000 shares $571.06 million +0.9%22.2%9.9 $73.78
5/15/20237,670,000 shares $596.50 million -4.0%22.0%9.1 $77.77
4/30/20237,990,000 shares $571.52 million +1.9%23.3%8.9 $71.53
4/15/20237,840,000 shares $537.04 million -4.5%22.8%8.6 $68.50
3/31/20238,210,000 shares $506.39 million -3.8%23.9%8.7 $61.68
3/15/20238,530,000 shares $528.26 million +1.6%24.8%8.9 $61.93
2/28/20238,400,000 shares $572.80 million +4.4%24.5%8.5 $68.19
2/15/20238,050,000 shares $508.28 million +5.4%23.5%6.9 $63.14
1/31/20237,640,000 shares $573 million -3.8%21.6%6.2 $75.00
1/15/20237,940,000 shares $534.36 million +5.2%22.4%5.9 $67.30
12/30/20227,550,000 shares $582.33 million +2.4%21.3%5.4 $77.13
12/15/20227,370,000 shares $570.88 million -7.1%20.8%5.1 $77.46
11/30/20227,930,000 shares $573.26 million +16.8%22.8%5.3 $72.29
11/15/20226,790,000 shares $372.91 million +9.0%19.5%5.2 $54.92
10/31/20226,230,000 shares $281.28 million +8.5%19.3%3.6 $45.15
10/15/20225,740,000 shares $275.52 million +2.5%17.8%3.7 $48.00
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
9/30/20225,600,000 shares $249.87 million -1.8%17.4%3.8 $44.62
9/15/20225,700,000 shares $351.63 million -3.7%17.7%2.9 $61.69
8/31/20225,920,000 shares $377.70 million +8.4%18.5%3.1 $63.80
8/15/20225,460,000 shares $258.64 million -5.0%17.1%3 $47.37
7/31/20225,750,000 shares $221.89 million -3.9%18.7%4.2 $38.59
7/15/20225,980,000 shares $261.27 million +7.4%19.5%4.1 $43.69
6/30/20225,570,000 shares $213.33 million +6.5%18.1%3.4 $38.30
6/15/20225,230,000 shares $120.29 million +4.8%17.0%3.6 $23.00
5/31/20224,990,000 shares $124.75 million +2.5%16.3%4.7 $25.00
5/15/20224,870,000 shares $135.87 million +7.7%15.9%4.6 $27.90
4/30/20224,520,000 shares $143.51 million -0.9%14.8%4.3 $31.75
4/15/20224,560,000 shares $168.08 million -4.6%15.0%4.7 $36.86
3/31/20224,780,000 shares $197.84 million +5.8%15.9%6.6 $41.39
3/15/20224,520,000 shares $131.67 million +2.3%15.0%7 $29.13
2/28/20224,420,000 shares $124.25 million +17.6%14.7%7.1 $28.11
2/15/20223,760,000 shares $126.90 million +8.4%12.7%6.3 $33.75
1/31/20223,470,000 shares $95.22 million +4.2%11.8%5.5 $27.44
1/15/20223,330,000 shares $95.24 million -2.9%11.3%5.5 $28.60
12/31/20213,430,000 shares $129.59 million -5.0%11.6%5.4 $37.78
12/15/20213,610,000 shares $118.30 million +2.9%12.2%5 $32.77
11/30/20213,510,000 shares $121.24 million +7.7%11.9%4.2 $34.54
11/15/20213,260,000 shares $125.44 million -2.1%11.0%3.5 $38.48
10/29/20213,330,000 shares $128.21 million -11.4%11.2%2.5 $38.50
10/15/20213,760,000 shares $150.78 million -0.3%12.7%2.6 $40.10
9/30/20213,770,000 shares $124.26 million +12.5%12.7%2.8 $32.96
9/15/20213,350,000 shares $92.86 million -16.5%11.3%2.7 $27.72
8/31/20214,010,000 shares $102.98 million +17.9%13.5%3.5 $25.68
8/13/20213,400,000 shares $77.72 million +15.3%11.5%3.4 $22.86
7/30/20212,950,000 shares $143.34 million +8.5%10.0%4.8 $48.59

AXSM Short Interest - Frequently Asked Questions

Short interest is the volume of Axsome Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 2,634,115 shares of AXSM short. 6.45% of Axsome Therapeutics' shares are currently sold short. Learn More on Axsome Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AXSM shares currently have a short interest ratio of 1.6. Learn More on Axsome Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.45% of Axsome Therapeutics' floating shares are currently sold short.

Axsome Therapeutics saw a decrease in short interest in June. As of June 30th, there was short interest totaling 2,634,115 shares, a decrease of 19.8% from the previous total of 3,282,463 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

6.45% of Axsome Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Axsome Therapeutics: Jazz Pharmaceuticals PLC (5.81%), Revolution Medicines, Inc. (6.56%), Teva Pharmaceutical Industries Ltd. (2.80%), BeOne Medicines Ltd. - Sponsored ADR (0.77%), Moderna, Inc. (15.03%), Roivant Sciences Ltd. (5.18%), Insmed, Inc. (7.55%), BioNTech SE Sponsored ADR (1.14%), Viatris Inc. (4.13%), Genmab A/S Sponsored ADR (1.36%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($82.01 billion), Invesco QQQ ($47.15 billion), iShares Russell 2000 ETF ($24.07 billion), Nebius Group N.V. ($16.85 billion), Western Digital Corporation ($14.29 billion), SPDR S&P Biotech ETF ($11.89 billion), VanEck Semiconductor ETF ($11.29 billion), KLA Corporation ($10.37 billion), iShares 20+ Year Treasury Bond ETF ($8.78 billion), and Lumentum Holdings Inc. ($8.29 billion). View all of the most shorted stocks.

Short selling AXSM is an investing strategy that aims to generate trading profit from Axsome Therapeutics as its price is falling. AXSM shares are trading down $8.36 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Axsome Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AXSM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXSM, twice per month. The most recent reporting period available is June, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like AXSM:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:AXSM) was last updated on 7/10/2026 by MarketBeat.com Staff.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel